Highly efficient lentiviral gene transfer in CD34+ and CD34+/38-/lin- cells from mobilized peripheral blood after cytokine prestimulation

Stem Cells

Volumn 21, Issue 4, 2003, Pages 472-480

  Géronimi, Fabien ^a   Richard, Emmanuel ^a   Redonnet Vernhet, Isabelle ^a   Lamrissi Garcia, Isabelle ^a   Lalanne, Magalie ^a   Ged, Cécile ^a   Moreau Gaudry, François ^a   De Verneuil, Hubert ^a,b  

^a Federative Research Institute 66   (France)

^b INSERM   (France)

Author keywords

CD34+; CD34+ 38 lin ; Gene transfer; Lentiviral vector; Mobilized peripheral blood; Prestimulation

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE; ELONGATION FACTOR 1ALPHA; ENHANCED GREEN FLUORESCENT PROTEIN; FLT3 LIGAND; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 3; LENTIVIRUS VECTOR; PURINE; STEM CELL FACTOR; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CELL; CELL CULTURE; COLONY FORMING CELL; CULTURE MEDIUM; DNA SEQUENCE; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; LIQUID CULTURE; PROMOTER REGION; TARGET CELL; UMBILICAL CORD BLOOD; VIRAL GENE DELIVERY SYSTEM;

LENTIVIRUS; MARMOTA MONAX;

EID: 0038787487     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.21-4-472     Document Type: Article

References (45)

1. Kohn DB. Gene therapy for genetic haematological disorders and immunodeficiencies. J Intern Med 2001;249:379-390.
2. Brenner MK. Gene transfer and the treatment of haematological malignancy. J Intern Med 2001;249:345-358.
3. Buchschacher GL Jr, Wong-Staal F. Approaches to gene therapy for human immunodeficiency virus infection. Hum Gene Ther 2001;12:1013-1019.
4. Moritz T, Patel VP, Williams DA. Bone marrow extracellular matrix molecules improve gene transfer in human hematopoietic cells via retroviral vectors. J Clin Invest 1994;93:1451-1457.
5. Hanenberg H, Xiao XL, Dilloo D et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996;2:876-882.
6. Kiem HP, Andrews RG, Morris J et al. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand and megakaryocyte growth and development factor. Blood 1998;92:1878-1886.
7. Miller AD, Retroviral vectors. Curr Top Microbiol Immunol 1992;158:1-24.
8. Dunbar CE, Young NS. Gene marking and gene therapy directed at primary hematopoietic cells. Curr Opin Hematol 1996;3:430-437.
9. Kang EM, Hanazano Y, Frare P et al. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with fanconi anemia C gene after conditioning with low-dose irradiation. Mol Ther 2001;3:911-919.
10. Bagnis C, Chabannon C, Gravis G et al. Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy. Exp Hematol 2002;30:108-115.
11. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are active replicating at the time of infection. Mol Cell Biol 1990;10:4239-4242.
12. Van der Loo JC, Ploemacher RE. Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood 1995;85:2598-2606.
13. Peters SO, Kittler EL, Ramshaw HS et al. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996;87:30-37.
14. Pollok KA, Van der Loo JC, Cooper RJ et al. Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood. Hum Gene Ther 2001;12:2095-2108.
15. Naldini L, Blomer U, Gallay P et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272:263-267.
16. Blömer U, Naldini L, Kafri T et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997;71:6641-6649.
17. Miyoshi H, Takahashi M, Gage FH et al. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA 1997;94:10319-10323.
18. Kafri T, Blömer U, Peterson DA et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997;17:314-317.
19. Sutton RE, Wu HT, Rigg R et al. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J Virol 1998;72:5781-5788.
20. - human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA 1999;96:2988-2993.
21. Sutton RE, Reitsma MJ, Uchida N et al. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J Virol 1999;73:3649-3660.
22. 1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood 1997;89:465-472.
23. Gothot A, Van der Loo JC, Clapp DW et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998;92:2641-2649.
24. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000;288:669-672.
25. Hacein-Bey-Abina S, Le Deist F, Carlier F et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002;346:1185-1193.
26. Onodera M, Ariga T, Kawamura N et al. Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency. Blood 1998;91:30-36.
27. Aiuti A, Vai S, Mortellaro A et al. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nat Med 2002;8:423-425.
28. Aiuti A, Slavin S, Aker M et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002;296:2410-2413.
29. + cells. Hum Gene Ther 1998;9:1025-1036.
30. + cells from patients with Gaucher disease: in vivo detection of transduced cells without myelablation. Hum Gene Ther 1998;9:2629-2640.
31. Malech HL, Maples PB, Whiting-Theobald N et al. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci USA 1997;94:12133-12138.
32. Saulnier SO, Steinhoff D, Dinauer MC et al. Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells. J Gene Med 2000;2:317-325.
33. Ramezani A, Hawley TS, Hawley RG. Lentiviral vectors for enhanced gene expresion in human hemaopoietic cells. Mol Ther 2000;2:458-469.
34. + cells from patients with X-linked chronic granulomatous disease. Blood 2002;100:4381-4390.
35. +-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 2001;3:438-447.
36. + cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis. Hum Gene Ther 2001;12:401-413.
37. + NOD/SCID-repopulating cells. Blood 2002;99:709-712.
38. Imren S, Payen E, Westerman KA et al. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells. Proc Natl Acad Sci USA 2002;99:14380-14385.
39. Woods NB, Muessig A, Schmidt M et al. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. Blood 2003;101:1284-1289.
40. Li Z, Düllmann J, Schiedlmeier B et al. Murine leukemia induced by retroviral gene marking. Science 2002;296:497.
41. Buckley RH. Gene therapy for SCID - a complication after remarkable progress. Lancet 2002;360:1185-1186.
42. Lemoine NR. Risks and benefits of gene therapy for immunodeficiency: a reality check. Gene Ther 2002;9:1561-1562.
43. 1 human hematopoietic stem cells. Proc Natl Acad Sci USA 1998;95:11939-11944
44. - cell transduction via lentivirus-based gene transfer vectors. Hum Gen Ther 1999;10:1479-1489.
45. Björgvinsdottir H, Bryder D, Sitnicka E et al. Efficient oncoretroviral transduction of extended long-term culture-initiating cells and NOD/SCID repopulating cells: enhanced reconstitution with gene-marked cells through an ex vivo expansion approach. Hum Gene Ther 2002;13:1061-1073.